Many medicines are available to treat kidney cancer. If one treatment doesn’t help or stops working, your health care provider may recommend another option. If you or a loved one has kidney cancer and ...

DENVER -- Patients with advanced kidney cancer treated with immune checkpoint inhibitors (ICIs) lived longer if they consumed a high-fiber diet, a small prospective study showed. The investigators ...

A study led by Roswell Park Comprehensive Cancer Center helps explain why a rare and hyper-aggressive subtype of kidney cancer is susceptible to immunotherapy—information that helped researchers ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

– Zanzalintinib in combination with nivolumab demonstrated an objective response rate of 63% and a disease control rate of 90% – – Additional results from dose-finding cohorts will also be presented – ...

Exelixis (EXEL) announced an update on their ongoing clinical study.

DENVER -- Planned treatment "holidays" can help lessen the toxicity burden of tyrosine kinase inhibitors (TKIs) for selected patients with advanced kidney cancer without harming treatment efficacy, ...

Fruzaqla and Tyvyt combination significantly improved progression-free survival and response rates in advanced renal cell carcinoma patients compared to standard monotherapies. The FRUSICA-2 trial ...

On the list of medical terms we’d rather never hear, cancer is at the top. But when it comes to fighting it, knowledge is incredibly powerful. Here, top doctors share the risk factors and symptoms of ...

"People with chronic kidney disease generally have no symptoms until they’re very near kidney failure," said kidney-health ...